Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Balance Sheet
Balance Sheet Decomposition
Dhg Pharmaceutical Joint-Stock Co
Current Assets | 4.6T |
Cash & Short-Term Investments | 2.8T |
Receivables | 624B |
Other Current Assets | 1.2T |
Non-Current Assets | 1.4T |
Long-Term Investments | 35.1B |
PP&E | 1.1T |
Intangibles | 178.1B |
Other Non-Current Assets | 75.6B |
Balance Sheet
Dhg Pharmaceutical Joint-Stock Co
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
496 492
|
420 713
|
603 189
|
549 777
|
75 836
|
70 328
|
0
|
0
|
94 134
|
62 858
|
|
Cash |
108 745
|
89 511
|
270 265
|
88 443
|
75 330
|
66 628
|
0
|
0
|
94 134
|
62 858
|
|
Cash Equivalents |
387 747
|
331 202
|
332 924
|
461 334
|
505
|
3 700
|
0
|
0
|
0
|
0
|
|
Short-Term Investments |
260 617
|
507 605
|
703 731
|
930 615
|
1 459 722
|
1 768 000
|
2 110 000
|
2 355 000
|
2 230 000
|
2 745 000
|
|
Total Receivables |
798 878
|
626 458
|
678 802
|
794 252
|
690 298
|
524 860
|
397 658
|
377 553
|
675 203
|
623 999
|
|
Accounts Receivables |
753 017
|
559 843
|
609 256
|
717 568
|
583 932
|
454 884
|
315 113
|
279 862
|
528 859
|
523 860
|
|
Other Receivables |
45 861
|
66 615
|
69 546
|
76 684
|
106 366
|
69 976
|
82 545
|
97 690
|
146 344
|
100 139
|
|
Inventory |
780 704
|
639 321
|
732 861
|
633 808
|
891 487
|
725 439
|
1 072 606
|
1 250 834
|
1 534 636
|
1 115 429
|
|
Other Current Assets |
49 560
|
27 277
|
27 490
|
30 732
|
30 294
|
45 297
|
103 656
|
201 368
|
108 219
|
56 718
|
|
Total Current Assets |
2 386 250
|
2 221 373
|
2 746 073
|
2 939 185
|
3 147 636
|
3 133 924
|
3 720 883
|
4 218 772
|
4 642 193
|
4 604 004
|
|
PP&E Net |
783 797
|
827 079
|
858 630
|
821 517
|
755 187
|
718 592
|
631 658
|
678 171
|
1 187 884
|
1 066 375
|
|
PP&E Gross |
783 797
|
827 079
|
858 630
|
821 517
|
755 187
|
718 592
|
631 658
|
678 171
|
1 187 884
|
1 066 375
|
|
Accumulated Depreciation |
357 083
|
440 755
|
515 345
|
592 766
|
606 606
|
686 346
|
833 289
|
896 228
|
970 764
|
1 133 567
|
|
Intangible Assets |
180 017
|
256 418
|
261 965
|
241 790
|
235 520
|
210 452
|
205 780
|
201 812
|
181 861
|
178 106
|
|
Note Receivable |
0
|
0
|
5 099
|
3 510
|
1 560
|
459
|
642
|
822
|
205
|
205
|
|
Long-Term Investments |
16 842
|
15 932
|
15 744
|
14 538
|
25 468
|
43 468
|
22 493
|
18 169
|
35 656
|
35 110
|
|
Other Long-Term Assets |
115 812
|
42 397
|
57 831
|
66 940
|
40 594
|
39 922
|
33 061
|
50 440
|
62 675
|
75 444
|
|
Total Assets |
3 482 718
N/A
|
3 363 199
-3%
|
3 945 342
+17%
|
4 087 480
+4%
|
4 205 964
+3%
|
4 146 819
-1%
|
4 614 517
+11%
|
5 168 187
+12%
|
6 110 474
+18%
|
5 959 243
-2%
|
|
Liabilities | |||||||||||
Accounts Payable |
261 374
|
224 957
|
291 703
|
262 987
|
145 750
|
120 317
|
201 220
|
364 379
|
217 976
|
167 297
|
|
Accrued Liabilities |
541 301
|
240 493
|
268 137
|
284 346
|
263 432
|
241 915
|
238 288
|
215 326
|
296 862
|
287 264
|
|
Short-Term Debt |
176 707
|
270 711
|
354 765
|
469 800
|
557 901
|
264 667
|
207 391
|
114 723
|
572 165
|
649 914
|
|
Other Current Liabilities |
140 307
|
43 471
|
103 353
|
247 804
|
34 404
|
78 001
|
110 801
|
117 108
|
102 239
|
685 817
|
|
Total Current Liabilities |
1 119 689
|
779 632
|
1 017 959
|
1 264 937
|
1 001 488
|
704 899
|
757 700
|
811 537
|
1 189 242
|
1 790 293
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
16 830
|
20 323
|
34 160
|
11 671
|
9 534
|
5 410
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
69 403
|
62 330
|
57 600
|
63 449
|
60 215
|
64 368
|
66 807
|
65 113
|
68 298
|
74 195
|
|
Total Liabilities |
1 205 923
N/A
|
862 286
-28%
|
1 109 719
+29%
|
1 340 057
+21%
|
1 071 237
-20%
|
774 677
-28%
|
824 507
+6%
|
876 650
+6%
|
1 257 540
+43%
|
1 864 488
+48%
|
|
Equity | |||||||||||
Common Stock |
871 643
|
871 643
|
871 643
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
1 307 461
|
|
Retained Earnings |
556 467
|
605 911
|
736 639
|
321 006
|
550 253
|
665 298
|
807 129
|
1 018 364
|
1 080 572
|
322 393
|
|
Additional Paid In Capital |
0
|
0
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
6 779
|
|
Treasury Stock |
456
|
16 121
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
849 140
|
1 039 479
|
1 220 562
|
1 112 177
|
1 270 236
|
1 392 604
|
1 668 641
|
1 958 933
|
2 458 123
|
2 458 123
|
|
Total Equity |
2 276 795
N/A
|
2 500 913
+10%
|
2 835 623
+13%
|
2 747 423
-3%
|
3 134 728
+14%
|
3 372 142
+8%
|
3 790 010
+12%
|
4 291 537
+13%
|
4 852 935
+13%
|
4 094 755
-16%
|
|
Total Liabilities & Equity |
3 482 718
N/A
|
3 363 199
-3%
|
3 945 342
+17%
|
4 087 480
+4%
|
4 205 964
+3%
|
4 146 819
-1%
|
4 614 517
+11%
|
5 168 187
+12%
|
6 110 474
+18%
|
5 959 243
-2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
131
|
130
|
131
|
131
|
131
|
131
|
131
|
131
|
131
|
131
|